-
Supernus Pharmaceuticals (NASDAQ:SUPN) Given Neutral Rating at Cantor Fitzgerald
Source: Buzz FX / 26 Feb 2025 08:41:20 America/Chicago
Supernus Pharmaceuticals (NASDAQ:SUPN) Given Neutral Rating at Cantor Fitzgerald Written by MarketBeat February 26, 2025 Share Link copied to clipboard. Supernus Pharmaceuticals ( NASDAQ:SUPN - Get Free Report ) 's stock had its "neutral" r
Read more...